The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Esber Henry Jemil since 2015.
The trader's CIK number is 1391501.
At the time of the last reporting, Esber Henry Jemil was the Director of Innovus Pharmaceuticals, Inc.. (stock ticker symbol INNV).
Also see all insider trading activities at Innovus Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | BTHE | 9,000 | $1,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | INNV | 100,000 | $9,500 | 0 | $0 | 0 | $0 |
1. Boston Therapeutics, Inc. (BTHE)
2. Innovus Pharmaceuticals, Inc. (INNV)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-18 | BTHE | Buy | 9,000 | .20 | 1,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-11-23 | INNV | Buy | 100,000 | .10 | 9,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Esber Henry Jemil (Director of Innovus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.